There are significant drug interactions of protease inhibitors and efavirenz with bedaquiline. Randomised trials have demonstrated that while ART reduces TB incidence in HIV‐infected patients, the addition of isoniazid preventive therapy further reduces TB incidence (37% to 56% reduction) in patients on ART including in patients with higher CD4 counts. Here, CD4 is linked to tuberculosis.